Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement

Contributed by: Business Wire

Logo

Tags

Health

General Health

Research

Pharmaceutical

Science

Biotechnology

PharmaBiome

More Like This

Human Biome Announces Prediction of first-in class, Biosynthetic Microbiome Against Silent Pandemic of Antibiotic-Resistant Bacteria and Doses First Patients in Contextual FMT Study to validate it

The Biocodex Group Strengthens Its Position in Microbiota, With the Signature of a Licensing Agreement With My Health, a Belgian Biotech Company Specializing in Microbiota Solutions

PR Newswire associated0

Crown Laboratories, Inc. and BIOJUVE® Celebrate World Microbiome Day 2024

MRM Health Initiates Clinical Research in Parkinson’s Disease

PR Newswire associated0

Microbiome Insights, Inc. Releases Updated Guide for Researchers Planning and Conducting Microbiome Studies

PR Newswire associated0

WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATION

Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring

PR Newswire associated0

As a new Core Lab under the Million Microbiomes from Humans Project, MGI empowers INRAE MetaGenoPolis in" Le microbiote français - Le French Gut "project to Propel Metagenomics Research